Skip to main content

Table 1 Comparison of clinical parameters between BCORMUT and BCORWT patients

From: Dynamics of epigenetic regulator gene BCOR mutation and response predictive value for hypomethylating agents in patients with myelodysplastic syndrome

Characteristics BCOR mutated (n = 43) BCOR wild-type (n = 633) p
Age (mean) (year) 55.8 55.9 0.970
Sex (M/F) (no) (ratio) 24/19 (1.3) 371/262 (1.4) 0.719
Normal chromosomes (n) (%) 31/43 (72.1) 355/633 (56.1) 0.040
RAEB (1 + 2) (n) (%) 23/43 (53.5) 174/633 (27.5) 0.008
IPSS ≥ 1.5 (n) (%) 15/43 (34.9) 149/633 (23.5) 0.093
AML transformation ratio (n) (%) 11/43 (25.6) 97/633 (15.3) 0.076
Median overall survival (m) 32 36 0.214
AML free survival (m) 16 35 0.035
  1. The p value less than 0.05 is expressed in italics, suggesting a statistical difference